Novartis Ireland Limited

Lobbying Organisation Novartis Ireland Limited

Date published 19 Jan, 2016

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Sep, 2015 to 31 Dec, 2015

Specific Details Highlighting the societal cost of multiple scelerosis

Intended results Better understanding of the significant cost of MS, most of which is outside the healthcare system, borne by society eg family, carers, time off work

Name of person primarily responsible for lobbying on this activity Susanne O'Reilly

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Event / Reception (1)

October 2015 (Dublin), launch of the Societal Cost of MS. MS (multiple sclerosis) costs Irish society more than €429m each year resulting from direct costs, indirect costs, intangible costs and costs associated with relapse. The report, is based on an original piece of research carried out by MS Ireland, supported by Novartis. The report's recommendations are: 1. Access to interventions that reduce relapses and disability progression, support working and living independently 2. Improving employment opportunities

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Maureen O'Sullivan TD (Dáil Éireann, the Oireachtas)

Sandra McLellan TD (Dáil Éireann, the Oireachtas)